Publicacións (10) Publicacións de Alba Calvo Bacaicoa

filter_list

2024

  1. Unveiling the immunomodulatory effect of the novel probiotic Akkermansia muciniphila and its protective effect in vitro

    Microbiological Research, Vol. 283

2023

  1. Refining Immunogenicity through Intradermal Delivery of Outer Membrane Vesicles against Shigella flexneri in Mice

    International Journal of Molecular Sciences, Vol. 24, Núm. 23

2022

  1. Effect of topical berberine in murine cutaneous leishmaniasis lesions

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081

  2. Oral Immunogenicity of Enterotoxigenic Escherichia coli Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez® AN–Mannosamine Polymer Conjugate

    Pharmaceutics, Vol. 14, Núm. 1

2021

  1. Changes in the nanoparticle uptake and distribution caused by an intramacrophagic parasitic infection

    Nanoscale, Vol. 13, Núm. 41, pp. 17486-17503

  2. Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3197-3209

2020

  1. Berberine-loaded liposomes for the treatment of leishmania infantum-infected balb/c mice

    Pharmaceutics, Vol. 12, Núm. 9, pp. 1-18

2019

  1. Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions

    Pharmaceutics, Vol. 11, Núm. 11

2018

  1. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions

    Journal of Dermatological Science, Vol. 92, Núm. 1, pp. 78-88

2017

  1. Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.

    International Journal of Pharmaceutics, Vol. 533, Núm. 1, pp. 236-244